A settlement exceeding $1.3 million has been finalized between the forensic drug testing company, Avertest, and the U.S. Attorney’s Office for the Eastern District of Michigan. The agreement resolves allegations that Avertest violated the False Claims Act by improperly submitting claims for drug test payments. Notably, Avertest, which operates under the name Averhealth, consented to the $1,344,621 settlement without any determination of liability.
Riley’s complaint, filed in March 2021, asserts that approximately 30% of drug tests conducted by Avertest are inaccurate, sharply contrasting with the company’s claim of delivering forensically defensible results with a 97% accuracy rate. Additional details can be accessed through the original article.